165 related articles for article (PubMed ID: 18716553)
21. Survival and Prognostic Factors of Adult Intracranial Ependymoma: A Single-institutional Analysis of 236 Patients.
Zhao F; Wu T; Wang LM; Zhang J; Zhang H; Li SW; Zhang S; Li P; Wang B; Luo L; Liu PN
Am J Surg Pathol; 2021 Jul; 45(7):979-987. PubMed ID: 33739788
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Factors and Histopathological Features of Pediatric Intracranial Ependymomas: Nationwide Brain Tumor Registry-based Study of Japan.
Sasaki T; Uematsu Y; Fukai J; Tanaka S; Mukasa A; Saito N; Narita Y; Nakao N
Neurol Med Chir (Tokyo); 2022 Jul; 62(7):322-327. PubMed ID: 35545504
[TBL] [Abstract][Full Text] [Related]
23. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical markers for prognosis of ependymal neoplasms.
Korshunov A; Golanov A; Timirgaz V
J Neurooncol; 2002 Jul; 58(3):255-70. PubMed ID: 12187959
[TBL] [Abstract][Full Text] [Related]
25. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of the histological and molecular characteristics of ependymal tumors: a single institution case series from China.
Xi S; Sai K; Hu W; Wang F; Chen Y; Wang J; Zeng J; Chen Z
BMC Cancer; 2019 Jul; 19(1):717. PubMed ID: 31324163
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the prognostic significance of selected morphological and immunohistochemical markers in ependymomas, with literature review.
Zawrocki A; Iżycka-Świeszewska E; Papierz W; Liberski PP; Zakrzewski K; Biernat W
Folia Neuropathol; 2011; 49(2):94-102. PubMed ID: 21845537
[TBL] [Abstract][Full Text] [Related]
28. Spinal myxopapillary ependymomas: a retrospective clinical and immunohistochemical study.
Chen X; Li C; Che X; Chen H; Liu Z
Acta Neurochir (Wien); 2016 Jan; 158(1):101-7. PubMed ID: 26577638
[TBL] [Abstract][Full Text] [Related]
29. Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.
Hollon T; Nguyen V; Smith BW; Lewis S; Junck L; Orringer DA
J Neurosurg; 2016 Aug; 125(2):410-8. PubMed ID: 26745489
[TBL] [Abstract][Full Text] [Related]
30. Does Gross Total Resection Improve Progression-Free and Overall Survival in Pediatric Intracranial Ependymomas? Single-Center Clinical Experience Of 61 Cases.
Narin F; Bahadir S; Hanalioğlu Ş; Karakaya D; Başar I; Işikay I; Söylemezoğlu F; Akalan N; Bilginer B
World Neurosurg; 2022 Sep; 165():e469-e478. PubMed ID: 35772712
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical expression of cell cycle/apoptosis regulators and epidermal growth factor receptor in pediatric intracranial ependymomas.
Alexiou GA; Stefanaki K; Moschovi M; Patereli A; Prodromou N; Karentzou O
J Child Neurol; 2011 Feb; 26(2):195-8. PubMed ID: 20713981
[TBL] [Abstract][Full Text] [Related]
32. Infratentorial ependymomas: prognostic factors and outcome analysis in a multi-center retrospective series of 106 adult patients.
Guyotat J; Metellus P; Giorgi R; Barrie M; Jouvet A; Fevre-Montange M; Chinot O; Durand A; Figarella-Branger D
Acta Neurochir (Wien); 2009 Aug; 151(8):947-60. PubMed ID: 19499166
[TBL] [Abstract][Full Text] [Related]
33. Radiotherapy in addition to surgical resection may not improve overall survival in WHO grade II spinal ependymomas.
Brown DA; Goyal A; Takami H; Graffeo CS; Mahajan A; Krauss WE; Bydon M
Clin Neurol Neurosurg; 2020 Feb; 189():105632. PubMed ID: 31862631
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of Ki-67 (MIB-1) and p53 in ependymomas.
Suzuki S; Oka H; Kawano N; Tanaka S; Utsuki S; Fujii K
Brain Tumor Pathol; 2001; 18(2):151-4. PubMed ID: 11908872
[TBL] [Abstract][Full Text] [Related]
35. Prognosis by tumor location in adults with spinal ependymomas.
Oh MC; Kim JM; Kaur G; Safaee M; Sun MZ; Singh A; Aranda D; Molinaro AM; Parsa AT
J Neurosurg Spine; 2013 Mar; 18(3):226-35. PubMed ID: 23311515
[TBL] [Abstract][Full Text] [Related]
36. [Intracranial ependymomas in adult patients. Diagnosis and histological prognostic factors].
Figarella-Branger D; Metellus P; Barrié M; Maues de Paula A; Fernandez C; Polivka M; Vital A; Labrousse F; Vignaud JM; Laquerrière A; Rousselet MC; Lacroix C; Saikali S; Chapon F; Gontier MF; Chrétien F; Babin P; Rigau V; Vandenbos F; Peoc'h M; Kujas M; Chinot O; Gouvernet J; Giorgi R; Guyotat J; Jouvet A
Neurochirurgie; 2007 Jun; 53(2-3 Pt 1):76-84. PubMed ID: 17445840
[TBL] [Abstract][Full Text] [Related]
37. Prognostic relevance of localization and grading in intracranial ependymomas of childhood.
Ernestus RI; Schröder R; Stützer H; Klug N
Childs Nerv Syst; 1996 Sep; 12(9):522-6. PubMed ID: 8906366
[TBL] [Abstract][Full Text] [Related]
38. [Intracranial ependymomas in adult patients. Retrospective analysis of 121 cases from the multicentric French study].
Metellus P; Barrie M; Figarella-Branger D; Chinot O; Giorgi R; Jouvet A; Guyotat J
Neurochirurgie; 2007 Jun; 53(2-3 Pt 1):66-75. PubMed ID: 17475290
[TBL] [Abstract][Full Text] [Related]
39. Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases.
Stephen JH; Sievert AJ; Madsen PJ; Judkins AR; Resnick AC; Storm PB; Rushing EJ; Santi M
J Neurosurg Pediatr; 2012 Jun; 9(6):646-53. PubMed ID: 22656257
[TBL] [Abstract][Full Text] [Related]
40. The Effects of Surgery and Adjuvant Therapy on Survival Outcomes in Clear Cell Ependymomas: A Systematic Review and Meta-Analysis of Individual Patient Data.
Sheen Kweh BT; Rosenfeld J; Hunn M; Tee JW
World Neurosurg; 2021 Jan; 145():229-240. PubMed ID: 32949795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]